<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01347697</url>
  </required_header>
  <id_info>
    <org_study_id>NEAPE-2010-335-31M</org_study_id>
    <nct_id>NCT01347697</nct_id>
  </id_info>
  <brief_title>Collagen Implant Compared to Gluteus Maximus Flap for Reconstruction of Pelvic Floor After ELAPE/EAPE in Rectal Cancer</brief_title>
  <acronym>NEAPE</acronym>
  <official_title>Nordic Extended Abdominoperineal Excision (NEAPE) Study, a Randomized Clinical Trial Comparing a Collagen Implant With a Gluteus Maximus Flap for Reconstruction of Pelvic Floor After Extended Abdominoperineal Excision of Rectum in Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Society of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Västerbotten County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial compares two different techniques for reconstruction of the lesser pelvic floor
      after an extended abdominoperineal excision for locally advanced rectal cancer. The
      alternative reconstruction techniques in the trial are:

        -  a technique using a gluteus maximus myocutaneous flap or

        -  a technique using an acellular porcine collagen implant

      The primary endpoint will be physical performance six months from operation and our
      hypothesis is that the technique using an acellular porcine implant will cause less impaired
      physical performance compared to the technique using a myocutaneous flap.

      The study is interventional, randomized and by definition a comparative effectiveness
      research project.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extended abdominoperineal excision (EAPE) of the rectum is the potentially curative operation
      for rectal carcinomas too low for primary anastomosis, especially if the levator and
      sphincter musculature is infiltrated. This enlarged operation, when the levator musculature
      is excised en bloc with the rectum, creates a large defect. Primary closure is often not
      possible, and reconstruction with prosthetic material or a myocutaneous flap is necessary to
      avoid a perineal hernia. Implantation of a collagen sheet has shown preliminary good results
      and on the other hand, the use of a gluteus myocutaneous flap is routine in many clinics.
      There is a lack of scientific evidence to prove which method is better for the reconstruction
      of the lesser pelvic floor.

      The current study aims to compare the two reconstruction techniques.

      Centres that treat locally advanced rectal cancers with the extended abdominoperineal
      excision of rectum (EAPE)[Holm et al 2007] can participate provided that:

        1. the operative technique is standardized according to the study protocol

        2. the centre/unit has resources for examinations of participants by a physiotherapist or a
           nurse

        3. the centre/unit has one investigator in charge of the study locally

        4. the centre/unit has an operative volume that enables at least 6 patients to be
           included/randomised during the anticipated three year study phase for inclusions

      Centres that do not operate the rectal cancers included in this study can participate by
      arranging the preoperative examination and physical tests as well as follow-up of patients
      that are referred to other centres for the operation. In these cases the operating centre
      cares for the randomisation, operation and start of postoperative rehabilitation while the
      study follow-up and final rehabilitation can be completed at the patients' primary referral
      hospital. The primary referral hospital needs a site investigator in charge of study patients
      just like centres that do the operations.

      Patients with primary or recurrent cancers of rectal origin can be included but individual
      patients can be included only once. Concomitant therapies are allowed and preoperative or
      postoperative radiation therapy and/or chemotherapy may be given or not according to local
      multidisciplinary team (MDT) decisions.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance in Timed-Stands Test</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>Timed-Stands test is a combined measure of physical performance depending on at least muscle strength, balance, tenderness of gluteal skin and muscles and co-ordination of motion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in physical performance</measure>
    <time_frame>3, 6 and 12 months after surgery compared with preoperative results</time_frame>
    <description>Change in Timed-Stands Test performance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary wound healing assessed with the Southampton Wound Assessment Scale</measure>
    <time_frame>3 months from operation</time_frame>
    <description>The Southampton Wound Assessment Scale is a validated measure of wound healing after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications according to classification by Dindo-Clavien</measure>
    <time_frame>3, 6 and 12 months after surgery</time_frame>
    <description>The Dindo-Clavien classification of surgical complications is a validated instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of persistent perineal sinus or fistula</measure>
    <time_frame>3, 6 and 12 months after surgery</time_frame>
    <description>Proportion of patients with the wound healing defect of all patients in the particular study arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to sit</measure>
    <time_frame>3, 6 and 12 months after surgery</time_frame>
    <description>Ability to sit is graded with a scale in three degrees.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of pain and discomfort in gluteal region measured with VAS</measure>
    <time_frame>3, 6 and 12 months after surgery compared to preoperative</time_frame>
    <description>A standard visual analogue scale (VAS) from 0-100 mm is used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of quality of life measured with EQ-5D and EORTC forms C30 and CR29</measure>
    <time_frame>3, 6 and 12 months after surgery compared to preoperative</time_frame>
    <description>EQ-5D and EORTC are validated quality of life instruments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life spot measures</measure>
    <time_frame>3, 6 and 12 months after surgery</time_frame>
    <description>Quality of life at specified time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay, costs of surgical treatments and QALYs gained</measure>
    <time_frame>one year after surgery</time_frame>
    <description>Quality adjusted life year (QALY) is calculated using an quality of life utility index at repeated time points. The utility index is adjusted for the relevant background population.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Defect of Floor of Lesser Pelvis</condition>
  <arm_group>
    <arm_group_label>Porcine collagen implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reconstruction with an acellular porcine collagen implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gluteus maximus flap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Reconstruction with a gluteus maximus myocutaneous flap.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reconstruction with an acellular porcine collagen implant</intervention_name>
    <description>Reconstruction of floor of lesser pelvis with an acellular porcine collagen implant after extended excision of rectum including levator muscles in advanced low rectal cancer.</description>
    <arm_group_label>Porcine collagen implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reconstruction with a gluteus maximus myocutaneous flap</intervention_name>
    <description>Reconstruction of floor of lesser pelvis with an gluteus maximus myocutaneous flap after extended excision of rectum including levator muscles in advanced low rectal cancer.</description>
    <arm_group_label>Gluteus maximus flap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (18 years or older) rectal cancer patients where wide resection of pelvic floor
             muscles together with rectum and anal canal have made reconstruction of pelvic floor
             necessary i.e. primary suture of pelvic floor in the midline is not possible.
             Resection of coccyx is optional.

        Exclusion Criteria:

          -  Age less than 18 years

          -  Very large resections including partial resection of sacrum and patients considered
             for bilateral flap reconstruction

          -  Large concomitant resection of vaginal wall where total (vaginal) wound closure is not
             an option

          -  Expected survival less than one year at operation

          -  Patient do not sign informed consent document
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markku M Haapamäki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University, Department of Surgical and Perioperative Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jörgen Rutegård, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marja-Liisa Lammi-Tavelin, B.Sc.</last_name>
    <phone>+46-70-2012764</phone>
    <email>marjaliisa.lammitavelin@vll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markku M Haapamäki, MD, PhD</last_name>
    <phone>+46-90-7851221</phone>
    <email>markku.haapamaki@surgery.umu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tero Rautio, MD, PhD</last_name>
      <phone>+358-8-3152817</phone>
      <email>tero.rautio@ppshp.fi</email>
    </contact>
    <investigator>
      <last_name>Tero Rautio, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunderby County Hospital</name>
      <address>
        <city>Luleå</city>
        <zip>971 80</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Dahlberg, MD, PhD</last_name>
      <phone>+46-920 282000</phone>
      <email>michael.dahlberg@nll.se</email>
    </contact>
    <investigator>
      <last_name>Michael Dahlberg, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skåne Universtiy Hospital</name>
      <address>
        <city>Malmö</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Louise Lydrup, MD, PhD</last_name>
      <phone>+46-76-8890091</phone>
      <email>marie-louise.lydrup@skane.se</email>
    </contact>
    <investigator>
      <last_name>Marie-Louise Lydrup, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital, Solna</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Martling, MD, PhD</last_name>
      <phone>+46-8-51772802</phone>
      <email>anna.martling@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Anna Martling, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital, Department of Surgical and Perioperative Sciences</name>
      <address>
        <city>Umeå</city>
        <zip>901 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marja-Liisa Lammi-Tavelin, B.Sc.</last_name>
      <phone>+46-70-2012764</phone>
      <email>marjaliisa.lammitavelin@vll.se</email>
    </contact>
    <contact_backup>
      <last_name>Markku M Haapamäki, MD, PhD</last_name>
      <phone>+46-90-7851221</phone>
      <email>markku.haapamaki@surgery.umu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Markku M Haapamäki, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Påhlman, MD, PhD</last_name>
      <phone>+46-18-6110000</phone>
      <email>lars.pahlman@surgsci.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Helgi Birgisson, MD, PhD</last_name>
      <email>Helgi Birgisson &lt;Helgi.Birgisson@surgsci.uu.se&gt;</email>
    </contact_backup>
    <investigator>
      <last_name>Lars Påhlman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helgi Birgisson, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Västmanlands Sjukhus Västerås</name>
      <address>
        <city>Västerås</city>
        <zip>72189</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Smedh, MD, PhD</last_name>
      <phone>+46-70-3735576</phone>
      <email>kenneth.smedh@ltv.se</email>
    </contact>
    <contact_backup>
      <last_name>Maziar Nikberg, MD, PhD</last_name>
      <phone>070-4185721</phone>
      <email>maziar.nikberg@ltv.se</email>
    </contact_backup>
    <investigator>
      <last_name>Keneth Smedh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Östersund Hospital</name>
      <address>
        <city>Östersund</city>
        <zip>831 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pär Nordin, MD, PhD</last_name>
      <phone>+46-63-153000</phone>
      <email>par.nordin@jll.se</email>
    </contact>
    <investigator>
      <last_name>Pär Nordin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007 Feb;94(2):232-8.</citation>
    <PMID>17143848</PMID>
  </reference>
  <reference>
    <citation>Haapamäki MM, Pihlgren V, Lundberg O, Sandzén B, Rutegård J. Physical performance and quality of life after extended abdominoperineal excision of rectum and reconstruction of the pelvic floor with gluteus maximus flap. Dis Colon Rectum. 2011 Jan;54(1):101-6. doi: 10.1007/DCR.0b013e3181fce26e.</citation>
    <PMID>21160320</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2011</study_first_submitted>
  <study_first_submitted_qc>May 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2011</study_first_posted>
  <last_update_submitted>June 2, 2016</last_update_submitted>
  <last_update_submitted_qc>June 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rectal neoplasms</keyword>
  <keyword>reconstructive surgical procedure</keyword>
  <keyword>bioprosthesis</keyword>
  <keyword>surgical flaps</keyword>
  <keyword>locomotion</keyword>
  <keyword>lesser pelvis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

